首页> 美国卫生研究院文献>other >Survival Benefit of Primary Prevention Implantable Cardioverter-Defibrillator Therapy After Myocardial Infarction: Does Time to Implant Matter?

【2h】

Survival Benefit of Primary Prevention Implantable Cardioverter-Defibrillator Therapy After Myocardial Infarction: Does Time to Implant Matter?

机译：在心肌梗死后的初级预防植入型心脏除颤器治疗的生存效果：是否有时间植入物质？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundWhether there is an optimal time to place an implantable cardioverter-defibrillator (ICD) more than 40 days after myocardial infarction (MI) in guideline-eligible patients is unknown.

机译：背景：对于符合指南的患者，是否有最佳时间放置植入式心脏复律除颤器（ICD）40天以上。

著录项

期刊名称 other
作者
Paul L. Hess; Amy Laird; Rex Edwards; Gust H. Bardy; J. Thomas Bigger; Alfred E. Buxton; Arthur J. Moss; Kerry L. Lee; W.J. Hall; Richard Steinman; Paul Dorian; Al Hallstrom; Riccardo Cappato; Alan H. Kadish; Peter J. Kudenchuk; Daniel B. Mark; Sana M. Al-Khatib; Jonathan P. Piccini; Lurdes Y.T. Inoue; Gillian D. Sanders;
展开▼
作者单位

展开▼
年(卷),期 -1(10),6
年度 -1
页码 828–835
总页数 16
原文格式 PDF
正文语种
中图分类
关键词
implantable cardioverter-defibrillator sudden cardiac death myocardial infarction heart failure;

机译：植入式心脏复律除颤器;心脏猝死;心肌梗塞;心力衰竭;

相似文献

外文文献
中文文献
专利

1. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. [J] . Paul L Hess, Amy Laird, Rex Edwards, Heart rhythm: the official journal of the Heart Rhythm Society . 2013 ,第6期

机译：心肌梗死后一级预防性植入式心脏复律除颤器治疗的生存获益：植入时间是否重要？使用来自4个临床试验的患者水平数据进行的荟萃分析。
2. Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. [J] . Paul L Hess, Amy Laird, Rex Edwards, Heart rhythm: the official journal of the Heart Rhythm Society . 2013 ,第6期

机译：在心肌梗死后初步预防植入心脏病患者治疗的存活效果：植入物质吗？使用来自4项临床试验的患者级数据的META分析。
3. Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator among Older Patients: Does Age Matter? An Analysis of Pooled Data from 5 Clinical Trials [J] . Circulation. Cardiovascular quality and outcomes . 2015 ,第2期

机译：老年患者一级预防性植入式心脏复律除颤器的生存获益：年龄重要吗？来自5个临床试验的汇总数据分析
4. Primary Prevention of Sudden Death in Post-Infarction Patients: When ICD Implantation is Really Cost-effective [C] . S.C. HAMMILL International Workshop on Cardiac Arrhythmias . 2004

机译：梗死后患者猝死的初级预防：当ICD植入真正具有成本效益时
5. Impact of time-varying and time-invariant measures of adherence to secondary prevention therapies post-acute myocardial infarction: An application of marginal structural models (MSMs). [D] . Lokhandwala, Tasneem. 2013

机译：急性心肌梗死后坚持二级预防疗法的时变和时不变措施的影响：边缘结构模型（MSMs）的应用。
6. Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients: Does Age Matter? An Analysis of Pooled Data From 5 Clinical Trials [O] . Paul L. Hess, Sana M. Al-Khatib, Joo Y. Han, -1

机译：老年患者一级预防性植入式心脏复律除颤器的生存获益：年龄重要吗？来自5个临床试验的汇总数据分析
7. SURVIVAL BENEFIT OF THE PRIMARY PREVENTION IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR AMONG OLDER PATIENTS: DOES AGE MATTER? A PATIENT-LEVEL META-ANALYSIS OF 5 CLINICAL TRIALS [O] . Hess Paul L., Al-Khatib Sana, Han Joo Y., 2014

机译：老年患者中主要预防性可植入心脏复律除颤器的生存益处：年龄是否重要？ 5种临床试验的患者水平元分析

Survival Benefit of Primary Prevention Implantable Cardioverter-Defibrillator Therapy After Myocardial Infarction: Does Time to Implant Matter?

摘要

著录项

相似文献

相关主题

期刊订阅